Soncini, D., Orecchioni, S., Ruberti, S., Minetto, P., Martinuzzi, C., Agnelli, L., . . . Cea, M. (2019). The new small tyrosine kinase inhibitor ARQ531 targets acute myeloid leukemia cells by disrupting multiple tumor-addicted programs. Haematologica.
Chicago ZitierstilSoncini, Debora, et al. "The New Small Tyrosine Kinase Inhibitor ARQ531 Targets Acute Myeloid Leukemia Cells By Disrupting Multiple Tumor-addicted Programs." Haematologica 2019.
MLA ZitierstilSoncini, Debora, et al. "The New Small Tyrosine Kinase Inhibitor ARQ531 Targets Acute Myeloid Leukemia Cells By Disrupting Multiple Tumor-addicted Programs." Haematologica 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.